CANCER RESEARCH CENTER
CANCER RESEARCH CENTER
批准号:
8166211
负责人:
SURANGANIE DHARMAWARDHANE
金额:
$18.74万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2011-06-30
关键词:
AreaBiomedical ResearchCancer CenterCell NucleusCellsClinicalCollaborationsCommunitiesComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentDiseaseFacultyFosteringFundingGenomicsGoalsGrantGroup MeetingsHispanicsInstitutionJournalsMalignant NeoplasmsMinorityNCI Center for Cancer ResearchPathologyPatientsPilot ProjectsPreventionPreventiveProtein Array AnalysisRecording of previous eventsRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResearch SupportResearch TrainingResourcesSeriesSourceTestingTherapeuticTherapeutic AgentsTimeTissuesTrainingTranslational ResearchUnderrepresented MinorityUnited States National Institutes of Healthanticancer researchcancer preventioncancer therapyefficacy testingmalignant breast neoplasmmembermolecular markermouse modelnext generationnovelnovel therapeuticsprogramsrepository
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
中心,不一定是研究者的机构。
UCC在培训代表性不足的少数民族和开展基础生物医学研究方面有着成功的历史。 这是第一次,我们提出了一个以疾病为导向的中心,专注于癌症研究,有明显的潜力,以支持促进转化研究的机构研究议程。目前,UCC癌症研究人员致力于对作为乳腺癌预防剂的饮食化合物进行基础和转化研究,开发新型乳腺癌治疗药物,并鉴定转移性乳腺癌的分子标志物。 这项研究计划预计将培育和扩大拟议的癌症中心。
拟议的癌症研究中心的目标是建立癌症研究能力在UCC和增加少数民族参与癌症研究通过培训下一代的少数民族癌症研究人员。为了实现这一目标,将实现以下具体目标:1)扩大在UCC进行癌症研究的基础设施; 2)增加UCC癌症研究人员的数量; 3)在UCC发展转化和临床癌症研究; 4)建立癌症研究系列研讨会和癌症小组会议和期刊俱乐部的延续; 5)教育社区关于癌症预防/早期检测; 6)支持初级教员的试点项目。
该中心将由一名高级研究员领导,将分为三个主要领域:1)在细胞和小鼠模型中测试新型癌症治疗方法的疗效,2)癌症病理学的基因组和蛋白质阵列分析,3)建立主要来自西班牙裔患者的癌症组织库。癌症研究中心的目标是促进癌症预防和治疗的转化研究。 与RCMI/SRDU合作,我们将招募两名教师,而癌症研究中心将招募一名博士后实习生和一名技术人员来支持教师的研究。 这将加强和推动我们的最终目标,即建立一个活跃的癌症研究人员的核心。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
UCC has a successful history of training underrepresented minorities and conducting basic biomedical research. For the first time, we propose a disease-oriented center focused on cancer research that has clear potential to support the institutional research agenda of fostering translational research. Currently, UCC cancer investigators pursue basic and translational research on dietary compounds as breast cancer preventives, development of novel therapeutic agents for breast cancer, and identification of molecular markers for metastatic breast cancer. This research program is expected to be nurtured and expanded by the proposed cancer center.
The OBJECTIVE of the proposed Cancer Research Center is to build cancer research capacity at UCC and increase minority participation in cancer research by training the next generation of minority cancer researchers. To achieve this objective, the following SPECIFIC AIMS will be carried out: 1) Expand the infrastructure to conduct cancer research at UCC; 2) Increase the number of cancer researchers at UCC; 3) Develop translational and clinical cancer research at UCC; 4) Establish a seminar series on cancer research and continuation of the cancer group meetings and journal club; 5) Educate the community about cancer prevention/early testing; 6) Support a Pilot Project from a junior faculty member.
The center will be led by a senior researcher and will be organized into three main areas: 1) Testing the efficacy of novel cancer therapeutics in cell and mouse models, 2) genomic and protein array analysis of cancer pathology, 3) establishment of a cancer tissue repository from patients of mainly Hispanic origin. The GOAL of the Cancer Research Center is to facilitate translational research in the prevention and treatment of cancer. In collaboration with the RCMI/SRDU, we will recruit two faculty members while the Cancer Research Center will recruit one postdoctoral trainee and one technician to support the research of the faculty. This will reinforce and jumpstart our ultimate goal of creating a nucleus of active cancer researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MBQ-167 derivatives as antimetastatic cancer agents.
-
批准号:10628411
-
项目类别:
-
资助金额:$8.94万
-
财政年份:2023
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Molecular targets of soy isoflavones in breast cancer progression
-
批准号:8018265
-
项目类别:
-
资助金额:$9.33万
-
财政年份:2010
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Targeting breast cancer progression
-
批准号:10386319
-
项目类别:
-
资助金额:$11.62万
-
财政年份:2008
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Molecular targets of soy isoflavones in breast cancer progression
-
批准号:8628232
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2008
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Molecular targets of soy isoflavones in breast cancer progression
-
批准号:8133781
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2008
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Molecular targets of soy isoflavones in breast cancer progression
-
批准号:7684814
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2008
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Molecular targets of soy isoflavones in breast cancer progression
-
批准号:7499192
-
项目类别:
-
资助金额:$10.02万
-
财政年份:2008
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Molecular targets of soy isoflavones in breast cancer progression
-
批准号:7936312
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2008
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Molecular targets of soy isoflavones in breast cancer progression
-
批准号:9249605
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2008
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Resveratrol in breast cancer cell survival or apoptosis
-
批准号:7104693
-
项目类别:
-
资助金额:$7.11万
-
财政年份:2005
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Resveratrol in breast cancer cell survival or apoptosis
-
批准号:7037577
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2005
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Developmental Research Projects Program (DRPP)
-
批准号:9901302
-
项目类别:
-
资助金额:$247.2万
-
财政年份:2001
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Developmental Research Projects Program (DRPP)
-
批准号:10451486
-
项目类别:
-
资助金额:$238.45万
-
财政年份:2001
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Developmental Research Projects Program (DRPP)
-
批准号:10653218
-
项目类别:
-
资助金额:$129.37万
-
财政年份:2001
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
REGULATORY ROLE OF RAC AND CDC42 ON TUMOR METASTASIS
-
批准号:6377633
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2000
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
REGULATORY ROLE OF RAC AND CDC42 ON TUMOR METASTASIS
-
批准号:6199377
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2000
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Developmental Research Project Program
-
批准号:9134814
-
项目类别:
-
资助金额:$249.78万
-
财政年份:--
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Developmental Research Project Program
-
批准号:9282453
-
项目类别:
-
资助金额:$203.33万
-
财政年份:--
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
Developmental Research Project Program
-
批准号:9487250
-
项目类别:
-
资助金额:$249.78万
-
财政年份:--
-
负责人:SURANGANIE DHARMAWARDHANE
-
依托单位:
海外基金